(Q39112472)

English

Blood neutrophil to lymphocyte ratio as a predictor in patients with advanced hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy

scientific article published on 16 October 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Blood neutrophil to lymphocyte ratio as a predictor in patients with advanced hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

1 reference

based on heuristic

inferred from title

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

author name string

Takeshi Terashima

1

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Tatsuya Yamashita

2

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Noriho Iida

3

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Taro Yamashita

4

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Hidetoshi Nakagawa

5

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Kuniaki Arai

6

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Kazuya Kitamura

7

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Takashi Kagaya

8

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Yoshio Sakai

9

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Eishiro Mizukoshi

10

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Masao Honda

11

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Shuichi Kaneko

12

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

publication date

16 October 2014

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Hepatology Research

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12436

21 January 2018

Diagnosis of hepatocellular carcinoma: newer radiological tools

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12436

21 January 2018

Hepatocellular carcinoma with portal vein tumor thrombosis: clinical characteristics, prognosis, and patient survival analysis.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12436

21 January 2018

Sorafenib in advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12436

21 January 2018

Guideline on the use of new anticancer drugs for the treatment of Hepatocellular Carcinoma 2010 update

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12436

21 January 2018

Feasibility and efficacy of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma after sorafenib

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12436

21 January 2018

Cancer-related inflammation

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12436

21 January 2018

Immunity, Inflammation, and Cancer

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12436

21 January 2018

Viral and host inflammation-related factors that can predict the prognosis of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12436

21 January 2018

Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12436

21 January 2018

Neutrophil-to-lymphocyte ratio associated with mortality in early hepatocellular carcinoma patients after radiofrequency ablation

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12436

21 January 2018

Inflammatory markers are associated with outcome in patients with unresectable hepatocellular carcinoma undergoing transarterial chemoembolization

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12436

21 January 2018

Neutrophil-lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12436

21 January 2018

Management of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12436

21 January 2018

Increase in CD14+HLA-DR -/low myeloid-derived suppressor cells in hepatocellular carcinoma patients and its impact on prognosis.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12436

21 January 2018

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12436

21 January 2018

A novel and validated prognostic index in hepatocellular carcinoma: the inflammation based index (IBI).

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12436

21 January 2018

When progressive disease does not mean treatment failure: reconsidering the criteria for progression

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12436

21 January 2018

Pro-angiogenic cytokines for prediction of outcomes in patients with advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12436

21 January 2018

An Akt/hypoxia-inducible factor-1alpha/platelet-derived growth factor-BB autocrine loop mediates hypoxia-induced chemoresistance in liver cancer cells and tumorigenic hepatic progenitor cells.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12436

21 January 2018

A randomised phase II study of TSU-68 in patients with hepatocellular carcinoma treated by transarterial chemoembolisation

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12436

21 January 2018

Analysis of factors affecting recurrence of hepatocellular carcinoma after liver transplantation with a special focus on inflammation markers

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12436

21 January 2018

Identifiers

10.1111/HEPR.12436

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39112472&oldid=1808094637"